DuoStim protocol- a novel fertility preservation strategy for female oncology patients

References

• Anderson, R. A., Brewster, D. H., Wood, R., Nowell, S., Fischbacher, C., Kelsey, T. W., & Wallace, W. H. B. (2018). The impact of cancer on subsequent chance of pregnancy: A population-based analysis. Human Reproduction, 33(7), 1281–1290. https://doi.org/10.1093/humrep/dey216
   PubMed Web of Science ®Google Scholar
• Anderson, R. A., Davies, M. C., & Lavery, S. A, (2020). Elective egg freezing for non-medical reasons: Scientific impact paper no. 63. BJOG: An International Journal of Obstetrics and Gynaecology, 127(9), e113–e121. https://doi.org/10.1111/1471-0528.16025
   PubMed Web of Science ®Google Scholar
• Azim, A. A., Costantini-Ferrando, M., & Oktay, K. (2008). Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: A prospective controlled study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 26(16), 2630–2635. https://doi.org/10.1200/JCO.2007.14.8700
   PubMed Web of Science ®Google Scholar
• Baerwald, A. R., Adams, G. P., & Pierson, R. A. (2003). A new model for ovarian follicular development during the human menstrual cycle. Fertility and Sterility, 80(1), 116–122. https://doi.org/10.1016/s0015-0282(03)00544-2
   PubMed Web of Science ®Google Scholar
• Bedoschi, G., Navarro, P. A., & Oktay, K. (2016). Chemotherapy-induced damage to ovary: Mechanisms and clinical impact. Future Oncology, 12(20), 2333–2344. https://doi.org/10.2217/fon-2016-0176
   PubMed Web of Science ®Google Scholar
• Bonardi, B., Massarotti, C., Bruzzone, M., Goldrat, O., Mangili, G., Anserini, P., Spinaci, S., Arecco, L., Del Mastro, L., Ceppi, M., Demeestere, I., & Lambertini, M. (2020). Efficacy and safety of controlled ovarian stimulation with or without letrozole co-administration for fertility preservation: A systematic review and meta-analysis. Frontiers in Oncology, 10, 574669. https://doi.org/10.3389/fonc.2020.574669
   PubMed Web of Science ®Google Scholar
• Cakmak, H., Katz, A., Cedars, M. I., & Rosen, M. P. (2013). Effective method for emergency fertility preservation: Random-start controlled ovarian stimulation. Fertility and Sterility, 100(6), 1673–1680. https://doi.org/10.1016/j.fertnstert.2013.07.1992
   PubMed Web of Science ®Google Scholar
• Cakmak, H., & Rosen, M. P. (2015). Random-start ovarian stimulation in patients with cancer. Current Opinion in Obstetrics & Gynecology, 27(3), 215–221. https://doi.org/10.1097/GCO.0000000000000180
   PubMed Web of Science ®Google Scholar
• Cancer Research UK. (2021). Cancer Statistics for the UK. https://www.cancerresearchuk.org/health-professional/cancer-statistics-for-the-uk
   Google Scholar
• Chen, Q., & Kuang, Y. (2020). Oocyte retrieval in double stimulation. In: A. Malvasi & D. Baldini (Eds.), Pick Up and Oocyte Management., (pp.179–194) Springer.
   Google Scholar
• Cobo, A., García-Velasco, J., Domingo, J., Pellicer, A., & Remohí, J. (2018). Elective and onco-fertility preservation: Factors related to IVF outcomes. Human Reproduction, 33(12), 2222–2231. https://doi.org/10.1093/humrep/dey321
   PubMed Web of Science ®Google Scholar
• Doungkamchan, C., & Orwig, K. E. (2021). Recent advances: Fertility preservation and fertility restoration options for males and females. Faculty Reviews, 10, 55. https://doi.org/10.12703/r/10-55
   PubMedGoogle Scholar
• Holman, D. A. (2019). Fertility preservation in gynecologic cancer. Seminars in Oncology Nursing, 35(2), 202–210. https://doi.org/10.1016/j.soncn.2019.02.007
   PubMed Web of Science ®Google Scholar
• Kasum, M., Šimunić, V., Orešković, S., & Beketić-Orešković, L. (2014). Fertility preservation with ovarian stimulation protocols prior to cancer treatment. Gynecological Endocrinology : The Official Journal of the International Society of Gynecological Endocrinology, 30(3), 182–186. https://doi.org/10.3109/09513590.2013.860123
   PubMed Web of Science ®Google Scholar
• Kroener, L., Dumesic, D., & Al-Safi, Z. (2017). Use of fertility medications and cancer risk: a review and update. Current Opinion in Obstetrics & Gynecology, 29(4), 195–201. https://doi.org/10.1097/GCO.0000000000000370
   PubMed Web of Science ®Google Scholar
• Kuang, Y., Chen, Q., Hong, Q., Lyu, Q., Ai, A., Fu, Y., & Shoham, Z. (2014). Double stimulations during the follicular and luteal phases of poor responders in IVF/ICSI programmes (Shanghai protocol). Reproductive Biomedicine Online, 29(6), 684–691. https://doi.org/10.1016/j.rbmo.2014.08.009
   PubMed Web of Science ®Google Scholar
• Lo Presti, A., Ruvolo, G., Gancitano, R. A., & Cittadini, E. (2004). Ovarian function following radiation and chemotherapy for cancer. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 113 Suppl 1, S33–S40. https://doi.org/10.1016/j.ejogrb.2003.11.008
   PubMed Web of Science ®Google Scholar
• Oktem, O., & Oktay, K. (2007). Quantitative assessment of the impact of chemotherapy on ovarian follicle reserve and stromal function. Cancer, 110(10), 2222–2229. https://doi.org/10.1002/cncr.23071
   PubMed Web of Science ®Google Scholar
• Patrizio, P., & Sakkas, D. (2009). From oocyte to baby : A clinical evaluation of the biological efficiency of in vitro fertilization. Fertility and Sterility, 91(4), 1061–1066. https://doi.org/10.1016/j.fertnstert.2008.01.003
   PubMed Web of Science ®Google Scholar
• Practice Committee of the American Society for Reproductive Medicine. (2019). Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: A committee opinion. Fertility and Sterility, 112(6), 1022–1033. https://doi.org/10.1016/j.fertnstert.2019.09.013
   PubMed Web of Science ®Google Scholar
• Russo, M., Liu, K., & Chan, C. (2020). Suboptimal response to GnRH-agonist trigger during oocyte cryopreservation: A case series. Reproductive Biology and Endocrinology, 18(1), 59. https://doi.org/10.1186/s12958-020-00614-y
   PubMed Web of Science ®Google Scholar
• Sighinolfi, G., Sunkara, S. K., & La Marca, A. (2018). New strategies of ovarian stimulation based on the concept of ovarian follicular waves: From conventional to random and double stimulation. Reproductive Biomedicine Online, 37(4), 489–497. https://doi.org/10.1016/j.rbmo.2018.07.006
   PubMed Web of Science ®Google Scholar
• Soleimani, R., Heytens, E., Darzynkiewicz, Z., & Oktay, K. (2011). Mechanisms of chemotherapy-induced human ovarian aging: Double strand DNA breaks and microvascular compromise. Aging, 3(8), 782–793. https://doi.org/10.18632/aging.100363
   PubMedGoogle Scholar
• Sönmezer, M., Türkçüoğlu, I., Coşkun, U., & Oktay, K. (2011). Random-start controlled ovarian hyperstimulation for emergency fertility preservation in letrozole cycles. Fertility and Sterility, 95(6), 2125.e9–2125.e11. https://doi.org/10.1016/j.fertnstert.2011.01.030
   PubMed Web of Science ®Google Scholar
• Tsampras, N., Gould, D., & Fitzgerald, C. T. (2017). Double ovarian stimulation (DuoStim) protocol for fertility preservation in female oncology patients. Human Fertility , 20(4), 248–253. https://doi.org/10.1080/14647273.2017.1287433
   PubMed Web of Science ®Google Scholar
• Vaiarelli, A., Cimadomo, D., Trabucco, E., Vallefuoco, R., Buffo, L., Dusi, L., Fiorini, F., Barnocchi, N., Bulletti, F. M., Rienzi, L., & Ubaldi, F. M. (2018). Double stimulation in the same ovarian cycle (DuoStim) to maximize the number of oocytes retrieved from poor prognosis patients: A multicenter experience and SWOT analysis. Frontiers in Endocrinology, 9, 317. https://doi.org/10.3389/fendo.2018.00317
   PubMed Web of Science ®Google Scholar
• Vaiarelli, A., Cimadomo, D., Alviggi, E., Sansone, A., Trabucco, E., Dusi, L., Buffo, L., Barnocchi, N., Fiorini, F., Colamaria, S., Giuliani, M., Argento, C., Rienzi, L., & Ubaldi, F. M. (2020). The euploid blastocysts obtained after luteal phase stimulation show the same clinical, obstetric and perinatal outcomes as follicular phase stimulation-derived ones: A multicenter study. Human Reproduction, 35(11), 2598–2608. https://doi.org/10.1093/humrep/deaa203
   PubMed Web of Science ®Google Scholar
• Youssef, M. A., Van der Veen, F., Al-Inany, H. G., Mochtar, M. H., Griesinger, G., Nagi Mohesen, M., Aboulfoutouh, I., & van Wely, M. (2014). Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology. The Cochrane Database of Systematic Reviews, (10), CD008046. https://doi.org/10.1002/14651858.CD008046.pub4
   PubMed Web of Science ®Google Scholar